Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Ketamine × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 10 Breast 7 Head & Neck 6 Lymphoid 5 Other hematologic neoplasm 3 Other 2 Tumor-Agnostic 1 Thoracic 1 Plasma cell 1 Myeloid 1 Gynecologic 1 Genitourinary 1 Dermatologic 1 CNS 1

Conditions

Lung Neoplasms 1

Interventions

Carboplatin 941 Cisplatin 745 Pemetrexed 693 pembrolizumab 504 Paclitaxel 487 Docetaxel 454 Gemcitabine 349 Radiotherapy 322 Erlotinib Hydrochloride 313 Bevacizumab 270 Nivolumab 261 Etoposide 243 durvalumab 216 Drug Therapy 191 osimertinib 181 atezolizumab 174 Radiosurgery 158 Gefitinib 144 Vinorelbine 127 Magnetic Resonance Spectroscopy 105 130-nm albumin-bound paclitaxel 102 Ipilimumab 96 Cetuximab 95 Topotecan 87 Cyclophosphamide 87 tislelizumab 82 Irinotecan 80 anlotinib 78 Taxes 77 Albumin-Bound Paclitaxel 76

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00504725 2014-07-25

KITS

Duke University

Phase 2 Completed

40 enrolled 7 charts

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡